埃博拉疫苗战:成败或在几内亚

• 作 者: 唐琳
• 出 处: 科学新闻
• 发表日期: 2015年04期
• 关键词: 几内亚 博拉 疫苗 埃博拉病毒 埃博拉病 西岸 临床试验 最末端 这场 测试计划

从去年2月埃博拉西非疫情暴发至今,这场战役已经持续一整年。现在,埃博拉疫苗正式开启首次大规模测试,而其中的关键,或许就在几内亚。去年夏末,当两方学者开始为埃博拉病毒疫苗的临床试验做基础性工作的时候,位于西非西岸的几内亚,可能位列他们选择名单的最末端。从“被冷落”到“受期待”位列最末,原因有三。首先,与邻居塞拉利昂和利比里亚相比,几内亚每周感染埃博拉病毒的人数相对较少;

The campaign has lasted a full year since the outbreak of the Ebola outbreak in West Africa last February. Now that the first large-scale test was officially launched, the key to Ebola vaccine, perhaps in Guinea. Late last summer, Guinea, located in the West Bank West Bank, was likely to be at the very end of their list of options when both parties started to do basic work on clinical trials of the Ebola virus vaccine. From “being left out ” “to ” by the expectation "ranked last, for three reasons. First, Guinea has a relatively small number of weekly Ebola infections compared to its neighbors, Sierra Leone and Liberia;